Skip to content

25-G intraocular illumination combined with injection of viscoelastic agent into the suprachoroidal cavity for non-contact wide-angle lens condensation buckle surgery

25-G intraocular illumination combined with injection of viscoelastic agent into the suprachoroidal cavity for non-contact wide-angle lens condensation buckle surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093734
Enrollment
Unknown
Registered
2024-12-11
Start date
2024-12-14
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal detachment

Interventions

Suprachoroidal buckling surgery:None
Scleral buckling surgery:None

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients with rhegmatogenous retinal detachment confirmed clinically, including cases with single retinal hole or multiple retinal holes confined to one area, should meet the conditions of the disease that can be treated by suprachoroidal buckling surgery or comparative traditional scleral buckling surgery. 2.Patients aged from 1 to 65 years old, whose physical condition can tolerate the operation and follow-up examination are complete, and no serious systemic disease affects the ocular surgery and recovery process.

Exclusion criteria

Exclusion criteria: 1.Hemorrhagic or exudative retinal detachment. 2.Combined with other serious eye diseases (such as advanced glaucoma, uncontrollable intraocular inflammation, proliferative vitreoretinopathy above grade IV, etc.), which may interfere with the observation of the therapeutic effect of suprachoroidal buckling surgery. Patients with a history of previous intraocular surgery may have a significant impact on the results of this study. 3.Patients in whom cerclage was used intraoperatively.

Design outcomes

Primary

MeasureTime frame
Single-operation anatomic successful reattachment;Final postoperative anatomic successful reattachment;

Secondary

MeasureTime frame
The postoperative best-corrected visual acuity;The changes of diopters;The occurence of complications;

Countries

China

Contacts

Public ContactRonghan Wu

The Eye Hospital of Wenzhou Medical University

805620175@qq.com+86 577 8806 8871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026